Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedApr 16, 2014Pleo Nota- Quent DROPS 5XPenicillin Cross ContaminationTerra-Medica Inc. · D-1199-2014Class IITerminatedApr 16, 2014Pleo Not PORTABLE SIPS 7XPenicillin Cross ContaminationTerra-Medica Inc. · D-1198-2014Class IITerminatedApr 16, 2014Pleo Not PORTABLE SIPSPenicillin Cross ContaminationTerra-Medica Inc. · D-1197-2014Class IITerminatedApr 16, 2014Pleo Not PORTABLE SIPSPenicillin Cross ContaminationTerra-Medica Inc. · D-1196-2014Class IITerminatedApr 16, 2014Pleo Not DROPSPenicillin Cross ContaminationTerra-Medica Inc. · D-1195-2014Class IITerminatedApr 16, 2014Pleo Not TABLETS 5XPenicillin Cross ContaminationTerra-Medica Inc. · D-1194-2014Class IITerminatedApr 16, 2014Pleo Not CAPSULES 4XPenicillin Cross ContaminationTerra-Medica Inc. · D-1193-2014Class IITerminatedApr 16, 2014Pleo Not SUPPOSITORIES 3XPenicillin Cross ContaminationTerra-Medica Inc. · D-1192-2014Class IITerminatedApr 16, 2014Pleo Not OINTMENT 3XPenicillin Cross ContaminationTerra-Medica Inc. · D-1191-2014Class IIITerminatedApr 9, 2014QVAR¿ (beclomethasone dipropionate HFA)Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time pointTeva Pharmaceuticals USA · D-1190-2014Class IITerminatedApr 9, 2014HydrOXYzine HCl TabletsGood Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.American Health Packaging · D-1189-2014Class IITerminatedApr 9, 2014HydrOXYzine HCl TabletsGood Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.American Health Packaging · D-1188-2014Class IIITerminatedApr 9, 2014Suprax, Cefixime for Oral Suspension USPFailed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.Lupin Pharmaceuticals Inc. · D-1187-2014Class IIITerminatedApr 9, 2014Suprax, Cefixime for Oral Suspension USP 500 mg/5 mlFailed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.Lupin Pharmaceuticals Inc. · D-1186-2014Class IIITerminatedApr 9, 2014TivicayCross Contamination with Other Products: Product contains Promacta (eltrombopag).Viiv Healthcare Company · D-1185-2014Class IITerminatedApr 9, 2014Duloxetine Delayed-Release CapsulesFailed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a...Teva Pharmaceuticals USA · D-1184-2014Class IITerminatedApr 9, 2014Duloxetine Delayed-Release CapsulesFailed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a...Teva Pharmaceuticals USA · D-1183-2014Class IITerminatedApr 9, 2014Duloxetine Delayed-Release CapsulesFailed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a...Teva Pharmaceuticals USA · D-1182-2014Class IIITerminatedApr 2, 2014SETON PHARMACEUTICALS Fluocinolone Acetonide 0.01% Oil EAR DROPSSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1181-2014Class IIITerminatedApr 2, 2014SETON PHARMACEUTICALS Fluocinolone Acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1180-2014Class IIITerminatedApr 2, 2014SETON PHARMACEUTICALS Fluocinolone acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1179-2014Class IIITerminatedApr 2, 2014ROYAL PHARMACEUTICALS DermOtic Oil fluocinolone acetonide 0.01%Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1178-2014Class IIITerminatedApr 2, 2014ROYAL PHARMACEUTICALS Derma-Smoothe/FS fluocinolone acetonide 0.01%Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1177-2014Class IIITerminatedApr 2, 2014ROYAL PHARMACEUTICALS Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1176-2014Class IIITerminatedApr 2, 2014Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1175-2014Class IIITerminatedApr 2, 2014Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1174-2014Class IIITerminatedApr 2, 2014DermOtic OilSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-1173-2014Class IITerminatedMar 26, 2014DaytranaDefective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner...Noven Pharmaceuticals, Inc. · D-1172-2014Class IITerminatedMar 26, 2014DaytranaDefective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner...Noven Pharmaceuticals, Inc. · D-1171-2014Class ITerminatedMar 26, 2014Silver Sword capsulesMarketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active...Fabscout Entertainment, Inc · D-1170-2014Class ITerminatedMar 26, 2014Clalis capsulesMarketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active...Fabscout Entertainment, Inc · D-1169-2014Class IITerminatedMar 26, 2014Perrigo, Clindamycin Palmitate Hydrochloride for Oral SolutionPresence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.Paddock Laboratories, LLC · D-1168-2014Class IIITerminatedMar 26, 2014Venlafaxine HydrochlorideFailed Dissolution Specification: Out of Specification dissolution results at 12 month interval.McKesson Packaging Services · D-1167-2014Class IIITerminatedMar 26, 2014Advil PM CapletsSubpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.Pfizer Us Pharmaceutical Group · D-1166-2014Class IITerminatedMar 26, 2014Guaifenesin USPPresence of Foreign Matter: Guaifenesin API powder is being recalled due to the possibility that the product contains polyethylene fibers from a screen used to sift the...Traxx International Corp · D-1165-2014Class IITerminatedMar 26, 2014Hydroxyprogesterone Caproate 250mg/ml in Sesame OilCrystallization; visible crystals from the active ingredient formed due to extreme cold temperatures during shippingRX South LLC DBA RX3 Pharmacy · D-1164-2014Class ITerminatedMar 26, 20140.9% Sodium Chloride InjectionPresence of Particulate Matter: Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and...Baxter Healthcare Corp. · D-1163-2014Class ITerminatedMar 26, 20145% Dextrose InjectionPresence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and...Baxter Healthcare Corp. · D-1162-2014Class ITerminatedMar 26, 2014MarcainePresence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored.Hospira Inc. · D-1161-2014Class ITerminatedMar 26, 2014Clinimix 5/15 sulfite-freePresence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.Baxter Healthcare Corp. · D-1160-2014

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.